FDA's Top Regulator Hired As Pfizer Medical Director
Written by Chriss W. Street
The FDA revolving door with Big Pharma is spinning hard as Dr. Patrizia Cavazzoni, former Director of Drug Evaluation and Research that resigned ten days before President Trump took office, was just named as Pfizer’s Chief Medical Director.
Dr. Patrizia Cavazzoni will succeed Aida Habtezion, M.D., who served as Pfizer’s Chief Medical Director and Head of Worldwide Medical and Safety during the four years of the Biden Administration. A Pfizer release stated that Dr. Habtezion is leaving to “pursue other opportunities.”
There is no definitive public information available to confirm whether Dr. Patrizia Cavazzoni is a U.S. citizen. She was born and educated in Canada, earning her medical degree from McGill University in Montreal and completing her residency and fellowship at the University of Ottawa. Dr. Cavazzoni then joined the University of Ottawa as an Assistant Professor,before joining Pfizer for twenty-five years.
Dr. Cavazzoni seamlessly moved into the U.S. Food and Drug Administration in 2018, was named Acting Director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research (CDER) in 2020, and Director shortly after the Biden took office in January 2021.
Big Pharma developers were racing to develop effective vaccines against COVID-19 during Dr. Cavazzoni short stint as Acting Director of CDER. Despite lack of clinical trials that normally take 5 to 10 years to assess safety and efficacy of their products, U.S. authorities issued Pfizer’s BioNTech vaccine emergency and conditional use authorizations that allowed vaccines to be rolled out to the general populations.
This special pandemic treatment also waived Big Pharma’s liability and provided indemnification against any injury or death compensation and legal cost claims. As a result, Pfizer/BioNTech over the next four years made about $100 billion profit as the leader in providing 462 million doses of mRNA vaccine to all age groups.
It was known by CDER that the mRNA vaccine molecule becomes “self-replicating” once it enters human cell cytoplasm, where it will reproduce itself to yield large numbers of genomic copies. As a result of vaccination, human cells exposed to mRNA produce large amounts of the “payload” spike-protein.
Self-replicating systems are known to have rare eventsof “naked” RNA “transfection” that eventually lead to a lot of RNA being spread to organs and tissues in both the intended vaccine recipient and others who may be in close contact with the vaccine recipient.
The New York Times and the Washington Post claimed that according to CDER, there were no side effects from mRNA vaccines. Those parties making such claims were labeled as spreading misinformation and fraud.
But on March 17, 2023, the U.S. National Institute of Health’s National Center for Biotechnology Information published ‘Adverse Events Following COVID‐19 mRNA Vaccines: A Systematic Review of Cardiovascular Complication, Thrombosis, and Thrombocytopenia,’ that found extensive cardiovascular complications following the mRNA vaccination.
The NIH study confirmed 7,192 life-threatening adverse events associated with the Pfizer−BioNTech vaccine that included thrombosis, stroke, myocarditis, myocardial infarction, pulmonary embolism, and arrhythmia.
Pfizer Inc. (NYSE: PFE) announced Patrizia Cavazzoni, M.D. will serve as Chief Medical Officer, Executive Vice President. “In this role, Dr. Cavazzoni will lead Pfizer’s regulatory, pharmacovigilance, safety, epidemiology, and medical information and evidence generation, among other medical functions.”
Pfizer hailed Dr. Cavazzoni as a “world-class developer of medicines across a wide range of therapeutic modalities that has more than 25 years of experience in clinical development, pharmacovigilance, clinical operations, regulatory affairs, safety risk management, pharmacovigilance, epidemiology and R&D strategy.”